Who is sponsoring NCT02886754?

NCT02886754 is sponsored by University College Cork.

What drugs are being tested in NCT02886754?

Interventions in NCT02886754: Proficiency-based progression, National e-learning programme only, Standard simulation.

What condition does NCT02886754 study?

NCT02886754 studies Clinical Communication, ISBAR, Simulation, Proficiency-Based Progression, Non Technical Skills, Performance, Deteriorating Patient.

Is NCT02886754 still recruiting?

NCT02886754 is currently completed. Last updated 25 July 2017.

Last reviewed 2017-07-25 · How we verify

NCT02886754

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proficiency-Based Progression Training for Clinical Communication

Completed NA Last updated 25 July 2017

What this trial tests

NA trial testing Proficiency-based progression in Clinical Communication in 77 participants. Completed in 16 September 2016.

Timeline

14 September 2016

Primary endpoint
16 September 2016

16 September 2016

Quick facts

Lead sponsor	University College Cork
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	77
Start date	14 September 2016
Primary completion	16 September 2016
Estimated completion	16 September 2016
Sites	1 location across Ireland

Drugs / interventions tested

Proficiency-based progression
National e-learning programme only
Standard simulation

Conditions studied

Clinical Communication — all drugs for Clinical Communication →
ISBAR — all drugs for ISBAR →
Simulation — all drugs for Simulation →
Proficiency-Based Progression — all drugs for Proficiency-Based Progression →

Sponsor

University College Cork

Who can join

18 and older, any sex, with Clinical Communication or ISBAR. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Importance: Clinical communication is an important source of medical error and preventable adverse events. Objective: To determine the effectiveness of proficiency-based progression (PBP) simulation training for ISBAR (Identify, Situation, Background, Assessment, Recommendation) communication in the deteriorating patient. Setting: The study will be conducted in University College Cork, Ireland. Participants: Third year undergraduate nursing and fifth year medical students, who are scheduled to undertake ISBAR training as part of the National Early Warning Score (NEWS) programme. Intervention: Participants will be prospectively randomized to one of three groups before undertaking a performance assessment of an ISBAR communication relevant to a deteriorating patient in a high fidelity simulation laboratory: HSE group (the national e-learning programme only); S group (national e- learning plus simulation training) and PBP group (national e-learning plus proficiency-based progression simulation). Main outcome and measures: A proficiency benchmark on the performance of ISBAR communication in the context of an acutely deteriorating patient.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of a proficiency-based progression simulation programme on clinical communication for the deteriorating patient: a randomised controlled trial.
Breen D, O'Brien S, McCarthy N, Gallagher A, et al · · 2019 · cited 32× · PMID 31289064 · DOI 10.1136/bmjopen-2018-025992

Verify or expand the search:

Other University College Cork trials

Trials by the same sponsor.

NCT07481240 — A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families · NA · recruiting
NCT06857539 — Assessing Intellectual and Motor Outcomes in High-risk Infants · not yet recruiting
NCT07363928 — A Digital Cognitive Behavioural Therapy for Insomnia Intervention in Mild Cognitive Impairment and Mild Dementia · NA · completed
NCT06705582 — OASIS Study: Vitamin D Deficiency Prevention Among Older Adults in Ireland · NA · completed
NCT06709209 — AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02886754 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University College Cork
Last refreshed: 25 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02886754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing